These drugs work by targeting specific molecules involved in the angiogenesis process. For instance, they may inhibit the action of vascular endothelial growth factor (VEGF), a protein that stimulates the growth of new blood vessels. By blocking VEGF or its receptors, angiogenesis inhibitors can reduce or slow down the growth of tumors.
